Claim Missing Document
Check
Articles

Computational Identification of Prenylated Isoflavanones as Natural PTPN1 Inhibitors for Antidiabetic Drug Discovery Anderson Arnold Aloanis; Vlagia Indira Paat
Jurnal Kimia Fullerene Vol 9 No 2 (2024): Fullerene Journal Of Chemistry
Publisher : Fakultas Matematika dan Ilmu Pengetahuan Alam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37033/fjc.v9i2.625

Abstract

Protein tyrosine phosphatase non receptor type 1 (PTPN1) is a key negative regulator of insulin signaling and a validated therapeutic target for antidiabetic drug development. This study investigates the binding potential of three prenylated isoflavanones platyisoflavanone A, sophoraisoflavanone A, and erypogein D against PTP1B using molecular docking. Redocking of the native ligand yielded a low RMSD value (0.2953 Å), confirming the reliability of the docking protocol. All three compounds demonstrated strong predicted affinities and sub‑micromolar Ki values, with platyisoflavanone A showing the highest potency. Interaction analysis revealed that the isoflavanones occupy the catalytic pocket and engage key residues such as Tyr46, Asp48, Phe182, Ile219, and Gln262, supported by extensive hydrophobic contacts from the prenyl substituent. These findings indicate that prenylated isoflavanones possess structural features compatible with PTP1B inhibition and represent promising natural scaffolds for further development of antidiabetic agents.
Eksplorasi Potensi Bioaktif dan Target Protein Isoflavanon Terprenilasi dari Erythrina poeppigiana dengan Pendekatan In Silico Anderson Arnold Aloanis; Vlagia Indira Paat
Jurnal Kimia Fullerene Vol 8 No 2 (2023): Fullerene Journal of Chemistry
Publisher : Fakultas Matematika dan Ilmu Pengetahuan Alam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37033/fjc.v8i2.607

Abstract

Erythrina poeppigiana is a promising source of prenylated isoflavanones with diverse biological activities. This study aimed to evaluate the pharmacokinetic profiles and predict potential protein targets of Platyisoflavanone A, Erypogein D, and Sophoraisoflavanone A using SwissADME and SwissTargetPrediction. SwissADME analysis revealed that all compounds satisfied drug-likeness criteria, exhibited high gastrointestinal absorption, complied with Lipinski's rule of five, and showed a bioavailability score of 0.55. Protein target prediction identified Tyrosine-protein phosphatase non-receptor type 1 (PTPN1) and Tyrosinase (TYR) as the major targets with the highest probability values for all compounds. Several additional targets associated with inflammation and cell proliferation, including ALOX5, ALOX12, ALOX15, PTGES, PTGS2, ESR1, FGFR1, KDR, and MET, were also predicted. These findings indicate that the three prenylated isoflavanones possess a multitarget pharmacological profile and may have potential as anti-inflammatory and antiproliferative agents. This study provides a preliminary scientific basis for further molecular docking studies and biological validation.